{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:11:42Z","timestamp":1791101502423,"version":"4.1.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8,1]]},"DOI":"10.1093\/jac\/dkm159","type":"journal-article","created":{"date-parts":[[2007,7,26]],"date-time":"2007-07-26T03:28:52Z","timestamp":1185420532000},"page":"i57-i58","source":"Crossref","is-referenced-by-count":11,"title":["The priorities for antiviral drug resistance surveillance and research"],"prefix":"10.1093","volume":"60","author":[{"given":"Deenan","family":"Pillay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,8]]},"reference":[{"key":"key\n\t\t\t\t20171012054408_DKM159C1","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1073\/pnas.111085598","article-title":"RNA virus error catastrophe: direct molecular test by using ribavirin","volume":"98","author":"Crotty","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20171012054408_DKM159C2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00042560-200111010-00004","article-title":"Surrogate markers for disease progression in treated HIV infection","volume":"28","author":"Ghani","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20171012054408_DKM159C3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(99)11433-8","article-title":"Influenza virus neuraminidase inhibitors","volume":"355","author":"Gubavera","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171012054408_DKM159C4","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1371\/journal.pmed.0040013","article-title":"Modeling the worldwide spread of pandemic influenza: baseline case and containment interventions","volume":"4","author":"Colizza","year":"2007","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20171012054408_DKM159C5","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1097\/01.aids.0000189851.21441.f1","article-title":"A combination of decreased NRTI incorporation and decreased excision determines the resistance profile of HIV-1 K65R RT","volume":"19","author":"White","year":"2005","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171012054408_DKM159C6","doi-asserted-by":"crossref","first-page":"17355","DOI":"10.1073\/pnas.0607274103","article-title":"Genotypic predictors of human immunodeficiency virus type 1 drug resistance","volume":"103","author":"Rhee","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20171012054408_DKM159C7","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1371\/journal.pmed.0040036","article-title":"A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism","volume":"4","author":"Nijhuis","year":"2007","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20171012054408_DKM159C8","first-page":"S7","article-title":"Predictors of death, and response to therapy in patients with multi (three)-class drug resistant (MDR) HIV in the UK","volume":"10","author":"Grover","year":"2005","journal-title":"Antiviral Therapy"},{"key":"key\n\t\t\t\t20171012054408_DKM159C9","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bmj.38665.534595.55","article-title":"Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study","volume":"331","author":"Cane","year":"2005","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20171012054408_DKM159C10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1468-1293.2006.00424.x","article-title":"British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006)","volume":"7","author":"Gazzard","year":"2006","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20171012054408_DKM159C11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1053\/j.gastro.2006.07.013","article-title":"Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study","volume":"131","author":"Reesink","year":"2006","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171012054408_DKM159C12","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1128\/JVI.02628-05","article-title":"Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus","volume":"80","author":"Le Pogem","year":"2006","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20171012054408_DKM159C13","unstructured":"The Royal Society and the Academy of Medical Sciences 2006\n          Pandemic Influenza: Science to Policy\n          \n            http:\/\/www.royalsoc.ac.uk\/displaypagedoc.asp?id=22903 (4 April 2007, date last accessed)"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/60\/suppl_1\/i57\/3199786\/dkm159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T05:44:20Z","timestamp":1507787060000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/60\/suppl_1\/i57\/999663\/The-priorities-for-antiviral-drug-resistance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,1]]},"references-count":13,"journal-issue":{"issue":"suppl_1","published-online":{"date-parts":[[2007,8]]},"published-print":{"date-parts":[[2007,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkm159","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2007,8]]},"published":{"date-parts":[[2007,8,1]]}}}